Evidence map›Paper›PMID 28957316›Full record

ArticlePLoS genetics2017

The population genetics of human disease: The case of recessive, lethal mutations.

Carlos Eduardo G Amorim, Ziyue Gao, Zachary Baker, José Francisco Diesel, Yuval B Simons, Imran S Haque, Joseph Pickrell, Molly Przeworski

Erratum issuedAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The distribution of highly deleterious variants across human ancestry groups.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Mutation-selection-drift balance models of complex diseases.bioRxiv : the preprint server for biology · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Essential genes: a cross-species perspective.Mammalian genome : official journal of the International Mammalian Genome Society · 2023
    Review
  14. Quantifying the fraction of new mutations that are recessive lethal.Evolution; international journal of organic evolution · 2023
    Article
  15. Article
  16. The landscape of tolerated genetic variation in humans and primates.bioRxiv : the preprint server for biology · 2023
    Article
  17. Analysis of genetic dominance in the UK Biobank.Science (New York, N.Y.) · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Carlos Eduardo G AmorimDepartment of Biological Sciences, Columbia University, New York, NY, United States of America.ORCID http://orcid.org/0000-0002-8827-238X
Ziyue GaoHoward Hughes Medical Institution, Stanford University, Stanford, CA, United States of America.
Zachary BakerDepartment of Systems Biology, Columbia University, New York, NY, United States of America.
José Francisco DieselUniversidade Federal de Santa Maria, Santa Maria, RS, Brazil.
Yuval B SimonsDepartment of Biological Sciences, Columbia University, New York, NY, United States of America.
Imran S HaqueCounsyl, 180 Kimball Way, South San Francisco, CA, United States of America.
Joseph PickrellDepartment of Biological Sciences, Columbia University, New York, NY, United States of America.
Molly PrzeworskiDepartment of Biological Sciences, Columbia University, New York, NY, United States of America.

Funding

TRAINING IN CELLULAR, MOLECULAR AND BIOPHYSICAL STUDIEST32GM008224 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LIEM, RONALD K. · 1987 to 2021
$9.9M
The population genetics of disease risk and other quantitative traitsR01GM115889 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SELLA, GUY · 2015 to 2025
$2.9M
High-performance compute cluster for biomedical computingS10OD012351 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2012 to 2012
$2.0M
Natural selection in recent human evolutionR01GM121372 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PRZEWORSKI, MOLLY F · 2017 to 2020
$1.6M
Storage System for High Performance ComputingS10OD021764 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2016 to 2016
$600k
NIGMS NIH HHS R01 GM115889NIGMS NIH HHS R01 GM121372NIGMS NIH HHS T32 GM008224NIH HHS S10 OD012351NIH HHS S10 OD021764
6 · The paper itself

Abstract

Do the frequencies of disease mutations in human populations reflect a simple balance between mutation and purifying selection? What other factors shape the prevalence of disease mutations? To begin to answer these questions, we focused on one of the simplest cases: recessive mutations that alone cause lethal diseases or complete sterility. To this end, we generated a hand-curated set of 417 Mendelian mutations in 32 genes reported to cause a recessive, lethal Mendelian disease. We then considered analytic models of mutation-selection balance in infinite and finite populations of constant sizes and simulations of purifying selection in a more realistic demographic setting, and tested how well these models fit allele frequencies estimated from 33,370 individuals of European ancestry. In doing so, we distinguished between CpG transitions, which occur at a substantially elevated rate, and three other mutation types. Intriguingly, the observed frequency for CpG transitions is slightly higher than expectation but close, whereas the frequencies observed for the three other mutation types are an order of magnitude higher than expected, with a bigger deviation from expectation seen for less mutable types. This discrepancy is even larger when subtle fitness effects in heterozygotes or lethal compound heterozygotes are taken into account. In principle, higher than expected frequencies of disease mutations could be due to widespread errors in reporting causal variants, compensation by other mutations, or balancing selection. It is unclear why these factors would have a greater impact on disease mutations that occur at lower rates, however. We argue instead that the unexpectedly high frequency of disease mutations and the relationship to the mutation rate likely reflect an ascertainment bias: of all the mutations that cause recessive lethal diseases, those that by chance have reached higher frequencies are more likely to have been identified and thus to have been included in this study. Beyond the specific application, this study highlights the parameters likely to be important in shaping the frequencies of Mendelian disease alleles.

Indexed as

Genetics, PopulationGene FrequencyGenes, LethalGenes, RecessiveGenetic Diseases, InbornHeterozygoteHumansModels, GeneticMutationSelection, Genetic

Identifiers

PMID28957316
PMCPMC5619689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.